News

Article March 14, 2022

9 Things to Know about COVID-19 Immunity

Immunity is not as straightforward as you may think

Gladstone Experts COVID-19

Gladstone in the News March 9, 2022

Three Ways to Strengthen a Collaborative Culture

The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Infectious Disease Huang Lab Ott Lab Pollard Lab Srivastava Lab Weinberger Lab

Gladstone in the News March 9, 2022

Here’s Where Your Girl Scout Cookie Money Actually Goes

Eating Well—Girl Scouts can apply the proceeds of their cookie sales to many local causes or charities. In 2020, Troop 62171, located in Hillsborough, California, donated $1,000 to support COVID-19 research at Gladstone Institutes.

Donor Stories COVID-19

Gladstone in the News March 9, 2022

COVID-19 Linked to Neurological Symptoms, Studies Show

abc7 news—Senior Investigator Katerina Akassoglou, PhD, commenting on two recent studies that show long-term neurological symptoms in some COVID-19 patients, suggests that these symptoms could result from blood leaks into the brain, which can happen even during a minor infection.

Gladstone Experts COVID-19 Neurological Disease Akassoglou Lab

Gladstone in the News March 9, 2022

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.

Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab Ott Lab Yamanaka Lab Organoids

Article March 1, 2022

Gladstone Science Has Three Chances to Win STAT Madness

Gladstone discoveries compete head-to-head with other scientific advancements

Awards COVID-19 Traumatic Brain Injury Alzheimer’s Disease Huang Lab Paz Lab Weinberger Lab Chaturvedi

Article February 11, 2022

When Will This Pandemic End?

And other questions you have about Omicron and the pandemic

Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab Roan Lab

Video February 4, 2022

Omicron Update

In this COVID-19: Ask the Experts webinar, Gladstone virologists explain the latest science about the Omicron variant and answer questions about masking, testing, and more

Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab

Gladstone in the News February 4, 2022

Should We Go All in on Omicron Vaccines?

The Atlantic—Senior Investigator Melanie Ott, MD, PhD, explains that even with additional booster shots, a vaccine directed at the original coronavirus will eventually fail to protect us from new variants.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News January 26, 2022

Omicron Could Be the Beginning of the End of the COVID-19 Pandemic

Time—The Omicron variant of SARS-CoV-2 has spread around the world at an alarming rate, but some scientists think the variant might actually be a sign of hope. Nadia Roan explains that widespread infection may lead to widespread immunity, which could help turn the pandemic virus into an endemic virus. Warner Greene posits that the best-case scenario is that the virus will weaken, continuing to spread but without causing severe disease.

Gladstone Experts COVID-19 Infectious Disease Greene Lab Roan Lab

Article January 18, 2022

What You Should Know About Omicron

Gladstone virologists answer your most pressing questions about the latest variant of COVID-19

Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab Roan Lab

Gladstone in the News January 10, 2022

Moderna Announces People May Need 2nd Vaccine Booster, but Many Doctors Disagree

ABC News—COVID-19 vaccine maker Moderna recently announced that individuals might need a fourth shot to stay safe in the ongoing pandemic. Gladstone virologist Warner Greene argues that an additional dose of the available vaccine may not be ideal, and that future boosters should be designed to specifically protect against emerging strains of the virus.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News January 5, 2022

Indoor Dining May Once Again Be Too Risky Due to Omicron, Bay Area Health Experts Warn

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, recommends that people limit indoor dining, especially if they are over 65 or otherwise at elevated risk for COVID-19, while the Omicron wave washes over the Bay Area.

Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab

Gladstone in the News December 15, 2021

New COVID-19 Nasal Spray Therapy Aims to ‟Reduce Viral Load in the Lungs by 100-Fold”

abc7 NEWS—Senior Investigator Leor Weinberger, PhD, and Research Investigator Sonali Chaturvedi, PhD, explain their work on a therapy that sharply reduces viral load in the nose of hamsters after a single administration and could add a promising new tool to the therapeutic arsenal against COVID-19.

Gladstone Experts COVID-19 Infectious Disease Weinberger Lab

Gladstone in the News December 14, 2021

Virus-Hijacking COVID-19 Drug from Gladstone Researchers Slows Down Variants, Expects Clinical Trial Early Next Year

San Francisco Business Times—Senior Investigator Leor Weinberger, PhD, pioneered a new class of antivirals called therapeutic interfering particles (TIPs), which were recently shown to be effective against SARS-CoV-2 in animal models. The approach is now being developed by a startup company and will be headed to clinical trials.

Gladstone Experts COVID-19 Center for Cell Circuitry Infectious Disease Weinberger Lab